Biotechnology News

January 23, 2012

SCHAUMBURG, Ill.--(BUSINESS WIRE)--APP Pharmaceuticals has settled its litigation with The Medicines Company relating to APP’s Abbreviated New Drug Application for a generic version of the anti-clotting drug Angiomax® (bivalirudin).

January 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Selventa™, a biomarker discovery company that enables personalized healthcare through stratification of patients based on disease-driving mechanisms, today announced that the U.S. Patent & Trademark Office...

January 23, 2012

FRAMINGHAM, Mass. & TORRANCE, Calif.--(BUSINESS WIRE)--AB SCIEX and Phenomenex partner to improve food safety testing.

January 23, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--ZEVALIN Plus High Dose Chemotherapy (Z-BEAM) Highly Effective in Aggressive Lymphoma; Randomized Study Published in “CANCER”, the Journal of the American Cancer Society

January 23, 2012

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced that Stacy Enxing Seng has been appointed President of the Company’s Vascular Therapies Global Business Unit. She will...

January 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office (PTO) has issued a first, non-final Office Action in the...

January 23, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Vets Investment Banks for Capital Raise

January 23, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac’s Sciences Business Unit has achieved dual success in MHRA inspections at both its Craigavon Headquarters, Northern Ireland and Elvingston, Scotland sites. Both inspections were the first...

January 23, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostics company in the field of personalized medicine, announced today that its state-of-the-art, 13,448 sq.ft...

January 23, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) today announced that it received further encouraging guidance for the Phase III clinical and nonclinical development and...

January 20, 2012

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics Provides Update on PMA Application for LuViva® Advanced Cervical Scan and Timing for Filing of CE Mark

January 20, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced that the U.S. Food and Drug Administration (FDA) has approved a product label change for TYSABRI that will help enable...

January 20, 2012

WESTON, Mass. & DUBLIN--(BUSINESS WIRE)--FDA Updates TYSABRI® (natalizumab) Label to Include Anti-JC Virus Antibody Status as a PML Risk Factor

January 20, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel today announced the termination of certain license agreements with Talon Therapeutics and Par Pharmaceutical Companies, related to the Company's ondansetron HC1 oral spray product.

January 20, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, February 2, 2012, after market close, the Company will...

January 20, 2012

VIENNA, Va.--(BUSINESS WIRE)--The following letter is being released by CEL-SCI Corporation (NYSE AMEX: CVM) to its shareholders: Dear Fellow Shareholders: With the start of the New Year, I thought it would be helpful to provide you with a review...

January 20, 2012

--(BUSINESS WIRE)--BIO will present a new industry position on renewable chemicals and sustainable feedstocks at the Next Generation Renewable Chemical Summit

January 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced updated data from the Phase 1b portion of an ongoing Phase 1b/2 clinical trial of saridegib (also known as IPI-926) in combination with the...

January 20, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today reported positive preliminary data from the cohort of hepatocellular carcinoma (HCC) patients participating in the ongoing phase 2 randomized discontinuation trial (...

January 20, 2012

WASHINGTON--(BUSINESS WIRE)--BIO congratulates Fiberight on receiving a conditional loan guarantee for construction of a cellulosic biorefinery. BIO thanks USDA for loan guarantee to ensure capital flows to new technology.

January 20, 2012

LINCOLN, Neb.--(BUSINESS WIRE)--LI-COR Biosciences introduces a Quick Western Kit that reduces the overall time to complete a Western blot by approximately 90 minutes.

January 20, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--MSD (also known as Merck in the United States and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion...

January 20, 2012

SUNNYVALE, Calif.--(BUSINESS WIRE)--Amarantus BioSciences, Inc. (OTCBB:AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein, was interviewed by Stock News Now at the 2012 Biotech Showcase in San...

January 20, 2012

CINCINNATI--(BUSINESS WIRE)--STATKING Clinical Services will provide technical web content for a series of webinars hosted by Bioindustry Support Solutions.

January 20, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

January 20, 2012

ROCKFORD, Ill.--(BUSINESS WIRE)--Anderson Packaging, a business unit of AmerisourceBergen Consulting Group, received the Illinois Performance Excellence (ILPEx) Silver Award for "Progress Toward Excellence."

January 20, 2012

CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genzyme and Veracyte, Inc., today announced a global co-promotion partnership to provide a comprehensive solution for thyroid patients.

January 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera announces positive Phase 1b data from a trial of IMO-2055 in combination with Tarceva and Avastin

January 20, 2012

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company (OTCBB: LJPC) (the “Company” and “La Jolla”) today announced that it has acquired global development and commercialization rights to GCS-100, a novel therapeutic, from privately held...

January 20, 2012

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH) today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued an opinion recommending against conditional...

January 20, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Targets Booming Diabetes Research Market

January 20, 2012

LONDON--(BUSINESS WIRE)--PolyTherics acquires Warwick Effect Polymers and expands technology portfolio to enable the development of better biopharmaceuticals

January 20, 2012

--(BUSINESS WIRE)--Iris Pharma is a Contract Research Organization (CRO) providing preclinical and clinical research in Ophthalmology

January 19, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it intends to implement a strategic corporate restructuring, including an approximate 33% reduction in its...

January 19, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Avila has achieved the first milestone in its Epidermal Growth Factor Receptor (EGFR) Mutant-Selective Inhibitor alliance with Clovis Oncology triggering a $4 million milestone payment.

January 19, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Data on Navidea (NYSE Amex: NAVB)’s AZD4694 Presented by the Banner Institute at 6th Annual Human Amyloid Imaging Meeting: Poster presentations show assessment of fibrillar Amyloid–β (Aβ) deposition

January 19, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company’s investigational new drug (IND) application to begin clinical investigation of CO-...

January 19, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.225 per ordinary share. The dividend is payable on February 22, 2012, to shareholders of record on January...

January 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the fourth quarter and year ended December 31, 2011. The Company will host a conference call and webcast today at 5:00 p.m. ET to discuss...

January 19, 2012

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today announced that revenues for the first quarter of fiscal 2012 increased 18% to $133.7...

January 19, 2012

FORT LEE, N.J.--(BUSINESS WIRE)--Three Major IT Trends to Shape Life Sciences in 2012

January 19, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--ABN announced today the signing of a third agreement with Centrovet Laboratories, Santiago, Chile, for the delivery of a unique bi-valent vaccine to salmon and trout.

January 19, 2012

LYNN, Mass.--(BUSINESS WIRE)--Commonwealth Laboratories, Inc. and Health Point Press; publisher of “A New IBS Solution” by Dr. Mark Pimentel, are proud to announce their new partnership which will work to create and maintain multiple educational...

January 19, 2012

DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB: CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is very pleased to announce that the second patient suffering from basal cell carcinoma (skin...

January 19, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--The EMA granted Biovest with SME status, providing certain administrative and economic benefits related to the EU regulatory process for its BiovaxID personalized cancer vaccine.

January 19, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Verisk Health announced that its HEDIS® Performance Measurement solution has been certified by the National Committee for Quality Assurance (NCQA) and is ready for 2012 Healthcare Effectiveness Data and...

January 19, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--NanoIsrael 2012, the 3rd international conference & exhibition, which will be held on March 26th-27th, 2012, at the Tel–Aviv David Intercontinental Hotel, Israel, will focus this year on innovations and...

January 19, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Charitable Donation of $6.9 Million
to Support Cancer Patients